Literature DB >> 26468447

Cancer screening: Between appropriateness and effectiveness.

Mostafa A Arafa1.   

Abstract

Two similar words, effectiveness and efficacy, have comparable insight and nearly describe analogous meaning for a screening test, yet clear understanding and perception of their diverse meanings will help clarify the basis of the differing conclusions about whether screening tests for different cancers reduce morbidity and mortality. Screening test may not be effective even when it sounds to be efficacious, on the other hand it should be efficacious when the test is effective.

Entities:  

Keywords:  Cancer; Early detection; Effectiveness; Efficacy; Mortality; Screening test

Year:  2015        PMID: 26468447      PMCID: PMC4600185          DOI: 10.5306/wjco.v6.i5.109

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  3 in total

1.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

2.  Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.

Authors:  E A M Heijnsdijk; T M de Carvalho; A Auvinen; M Zappa; V Nelen; M Kwiatkowski; A Villers; A Páez; S M Moss; T L J Tammela; F Recker; L Denis; S V Carlsson; E M Wever; C H Bangma; F H Schröder; M J Roobol; J Hugosson; H J de Koning
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

3.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.